Category: Patents

May 24, 2022

Patents Medicine Press Releases Evecxia Therapeutics Announces Issuance of US Patent Covering EVX-101 for Depression and Other CNS Disorders

EVX-101 is a clinical-stage drug candidate currently being developed as...

MORE >

Latest Tweets Follow @DukeOLV

@DukeOTCRT @DukeUEnergy: ⚡️🌍All @DukeU students (and May '22 grads) can apply for the $10K Clean Energy Prize! Deadline 7/15. The award supports st…

@DukeOTCRT @374Water: The moment we have all been waiting for, 374Water is officially trading on Nasdaq under the symbol $SCWO! https://t.co/489j4x…

@DukeOTCIn a new OTC Blog, Daniel Dardani, our new Director of Physical Sciences and Digital Innovations Licensing and Corp… https://t.co/1C4ar5iDc8

@DukeOTCRT @Replicate_Bio: Together, we're pushing back the frontiers on manufacturing longer RNAs. Curia and Replicate Bioscience Enter Strategic…

@DukeOTCRT @DukeU: Crops around the globe face climate change and pollution, threatening food security. @DukeEngineering's Maiken Mikkelsen has dev…

@DukeOTCRT @dukeresearch: How fast are you aging? Do you look, act or feel younger or older than you should? By watching 1000 people grow old, thes…

@DukeOTCEvecxia Therapeutics announced the issuance of an additional US patent covering EVX-101 for depression and other ce… https://t.co/1tNtNHiQ7H

@DukeOTCWe are pleased to welcome Daniel Dardani to our team as Director of Physical Sciences and Digital Innovation Licens… https://t.co/Ph8n9FC7aM

@DukeOTCDr. Ornit Chiba-Falek, Chief Division of Translational Brain Sciences at @Duke_Neurology and CLAIRIgene co-founder… https://t.co/usdzJ4Y07o